Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Edwards Lifesciences Completes $4.2B Sale Of Critical Care To BD, Announces $1B Share Repurchase, And Board Authorizes Additional $1.5B For Future Buybacks

Author: Benzinga Newsdesk | September 03, 2024 04:34pm

- SEC Filing

Posted In: EW